A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion
Status:
Recruiting
Trial end date:
2025-10-31
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess the overall efficacy of a single
intervertebral local administration of AGA111 in patients with degenerative disc disease
undergoing lumbar interbody fusion.